63 - The Cost of Waiting Too Long on a High-Stakes Decision
What does it actually cost a CEO to wait for certainty?
Yi-Kai Lo faced that question while leading Aneuvo through an $8M clinical trial, an 11-month FDA process, and a product failure mid-study. In each case, the decision wasn’t just about risk — it was about whether delay itself had become the bigger risk.
“After analyzing the risk and benefit… the cost of keep delaying the study”
Yi-Kai Lo, CEO of Aneuvo, shares what it takes to lead a medical device company through high-stakes decisions where both action and delay carry real consequences.
From launching a clinical trial before receiving…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.